An investigation on behalf of current long term investors in Retrophin Inc (NASDAQ:RTRX shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ:RTRX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/21/2015 -- An investigation on behalf of current long-term investors in shares of Retrophin Inc (NASDAQ:RTRX) concerning potential breaches of fiduciary duties by certain directors and officers of Retrophin Inc was announced.
Investors who are current long term investors in Retrophin Inc (NASDAQ:RTRX) shares, have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ:RTRX stocks follows a lawsuit filed recently against Retrophin Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ:RTRX stocks, concerns whether certain officers and directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 27, 2014 and September 30, 2014 Defendants made allegedly false and/or misleading statements and/or allegedly failed to disclose that Retrophin Inc's founder and Chief Executive Officer was committing stock-trading irregularities and other violations of the Company's Incentive Compensation Plan and other securities rules, that said irregularities included grants of shares in violation of the Company's Incentive Compensation Plan and the failure to disclose stock grants to employees, and that as a result of the above, the Company's financial statements were materially false and misleading at all relevant times.
On September 16, 2014, after the close of trading, Retrophin Inc announced that on September 15, 2014, it had reached an agreement with its Chief Financial Officer, Marc Panoff, pursuant to which Mr. Panoff's employment with the Company will terminate, effective as of February 28, 2015. Also, Retrophin Inc announced that on September 10, 2014, Jeffrey Paley, MD stepped down as a member of the Board of Directors. Shares of Retrophin Inc declined to as low as $7.85 per share on October 1, 2014.
Those who purchased shares of Retrophin Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego